AMCP changes name of foundation, appoints new board members
The Academy of Managed Care Pharmacy has changed the foundation’s name to the Academy of Managed Care Pharmacy Foundation. In addition, it has elected four new members to its board of trustees, during the AMCP’s 25th annual meeting and exposition in San Diego.
The Academy of Managed Care Pharmacy has changed the foundation’s name to the Academy of Managed Care Pharmacy Foundation. In addition, it has elected 4 new members to its board of trustees, during the AMCP’s 25th annual meeting and exposition in San Diego.
New members to the AMCP Foundation’s board include: Annette D. Boyer, president of CECity, Inc.; Richard A. Zabinski, vice president, Prime Therapeutics, LLC; Edwin C. Hedblom, treasurer, 3M Medical; and Robert DeLuca, secretary of Archimedes Pharma US, Inc. Two trustees were re-elected to one-year terms: Perry Cohen, The Pharmacy Group, LLC, and Kathleen Kaa, Genentech USA.
“Since its inception in 1990, the AMCP Foundation has played an integral role in supporting the research and education agenda of AMCP. I welcome the newest members to our Board of Trustees and look forward to working with them to advance the professional development of healthcare practitioners in the managed care community,” said Edith A. Rosato, RPh, IOM, CEO of the Academy and Chair of the Foundation’s Board of Trustees.
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More
